Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The study is designed to determine the extent to which foods containing a plant-based ingredient affect blood glucose and hormonal response in healthy subjects.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Plant-based ingredient to a starchy meal | Other | Plant-based ingredient |
|
| Starchy meal alone | Other | No plant-based ingredient |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| plant-based ingredient | Dietary Supplement |
| ||
| No plant-based ingredient |
| Measure | Description | Time Frame |
|---|---|---|
| AUC of post-prandial hormones | Amylin (total) will be assessed. | 120 minutes |
| AUC of post-prandial hormones | Ghrelin (active) will be assessed. | 120 minutes |
| AUC of post-prandial hormones | Glucose-dependent insulinotropic peptide (gastric inhibitory polypeptide, GIP) (total) will be assessed. | 120 minutes |
| AUC of post-prandial hormones | Glucagon-like peptide-1 (GLP-1) (active) will be assessed. | 120 minutes |
| AUC of post-prandial hormones | Leptin will be assessed. | 120 minutes |
| AUC of post-prandial hormones | Pancreatic polypeptide (PP) will be assessed. | 120 minutes |
| AUC of post-prandial hormones | Peptide YY (PYY) (total) will be assessed. | 120 minutes |
| AUC of post-prandial hormones | Insulin will be assessed. | 120 minutes |
| AUC of post-prandial hormones |
| Measure | Description | Time Frame |
|---|---|---|
| AUC of post-prandial hormones | Amylin (total) will be assessed. | 180 and 240 minutes |
| AUC of post-prandial hormones | Ghrelin (active) will be assessed. |
| Measure | Description | Time Frame |
|---|---|---|
| Blood glucose response (+iAUC) | Effect on blood glucose response. | 120 and 180 minutes |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Yves DONAZZOLO, M.D., M.Sc. | EUROFINS OPTIMED, GIERES - France | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Eurofins Optimed Clinical research | Gières | France |
Not provided
Not provided
Not provided
Not provided
Not provided
| Dietary Supplement |
|
C-peptide will be assessed. |
| 120 minutes |
| AUC of post-prandial hormones | Glucagon will be assessed. | 120 minutes |
| 180 and 240 minutes |
| AUC of post-prandial hormones | Glucose-dependent insulinotropic peptide (gastric inhibitory polypeptide, GIP) (total) will be assessed. | 180 and 240 minutes |
| AUC of post-prandial hormones | Pancreatic polypeptide (PP) will be assessed. | 180 and 240 minutes |
| AUC of post-prandial hormones | Peptide YY (PYY) (total) will be assessed. | 180 and 240 minutes |
| AUC of post-prandial hormones | Leptin will be assessed. | 180 and 240 minutes |
| AUC of post-prandial hormones | Glucagon will be assessed. | 180 and 240 minutes |
| AUC of post-prandial hormones | Insulin will be assessed. | 180 and 240 minutes |
| AUC of post-prandial hormones | C-peptide will be assessed. | 180 and 240 minutes |
| AUC of post-prandial hormones | Glucagon-like peptide-1 (GLP-1) (active) will be assessed. | 180 and 240 minutes |